US EditionTakeda To Manufacture 50% Of Its Dengue Vaccines In India
Summary by Ground News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Takeda To Manufacture 50% Of Its Dengue Vaccines In India
Japanese drugmaker Takeda Pharmaceutical Co. announced a strategic partnership with Indian vaccine and biologics company Biological E. Ltd. to manufacture its dengue vaccine, TAK-003.The Indian partner is expected to "scale up its production capacity to potentially reach 50 million doses annually," the company said in a Feb. 27 release.This is further expected to accelerate Takeda's efforts to manufacture 100 million doses annually within the de…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
